Leibniz Healthy Ageing: LRA Healthy Ageing

Does a healthy lifestyle promote cognitive performance in old age? What new therapeutic approaches can be used to extend the health span in old age? What must the environment look like so that people can age healthy and satisfied? These are just a few examples of the pressing questions that society and politics are currently posing to science. The Leibniz Research Alliance Healthy Ageing wants to provide answers.

21 institutes of the Leibniz Association cooperate in the Leibniz Research Alliance Healthy Ageing. In addition, there are associated members from renowned research institutions in Germany and abroad. In interdisciplinary projects, they research the biological and social aspects of ageing. The interdisciplinary approach, which is unique in the German research landscape in this form, makes it possible to analyse the interactions between biological-medical and socio-economic aspects. The aim is to develop new adaptation strategies that promote healthy ageing in the long term. Biomedical scientists, educational researchers, spatial planners and economists work together in interdiciplinary teams.

New Biomarkers of Inflammation Identified as Risk Factors for Neuropathy
08/24/2018 · DDZ Deutsches Diabetes-Zentrum
Although many patients suffer from polyneuropathy, relatively little is currently known about its development, which also limits the therapeutic options. It is known that inflammatory processes contribute to other diabetic complications such as heart attack or stroke. The aim of this new study was therefore the extensive analysis of biomarkers that characterize inflammatory processes as a risk factor for distal sensory polyneuropathy (DSPN). Both people with type 2 diabetes and people in the elderly general population were examined.
read more
A molecular switch may serve as new target point for cancer and diabetes therapies
08/13/2018 · FMP Leibniz-Forschungsinstitut für Molekulare Pharmakologie
If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.
read more
Alexander von Humboldt Research Fellow at FLI
08/13/2018 · FLI Leibniz Institute on Aging - Fritz Lipmann Institute
Ukrainian cell biologist Dr. Yuliya Kurlishchuk has received a research fellowship for postdocs from the Alexander von Humboldt Foundation. With this funding, she is now a guest at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena for the next two years. She is going to investigate the regenerative capacity of cells in the research group “Transcriptional Control of Tissue Homeostasis” of Dr. Björn von Eyss.
read more

Issue 08Healthy Ageing - Forschung aus erster Hand

Issue 08
Healthy Ageing - Forschung aus erster Hand